Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 6:13 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 337–360 of 1,818 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Media Clear all

Conditions: Colo-rectal Cancer
Interventions: Now I'm Telling You; Behavioral
Lead sponsor: Richard Crosby; Other
Eligibility: 30 Years to 75 Years
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: HIV Infections
Interventions: Health Access Coalitions, Social Media, Peer Support, Promoting Human Autonomy Support & Empathy (PHASE); Behavioral
Lead sponsor: HIV Prevention Trials Network; Network
Eligibility: 15 Years and older · Male only
Enrollment: 2,700 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Obesity, Overweight
Interventions: Podcasting + mobile media; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 60 Years
Enrollment: 96 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Acute Otitis Media, AOMT
Interventions: 6 mg ciprofloxacin, 12 mg ciprofloxacin, Sham; Drug · Other
Lead sponsor: Otonomy, Inc.; Industry
Eligibility: 6 Months to 17 Years
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: San Diego, California

Conditions: Peripheral Arterial Disease
Interventions: Percutaneous Peripheral Intervention, Optical Coherence Tomography, Ankle Brachial Index, Six minute walk distance, Aspirin, Aspirin + Ticagrelor; Procedure · Device · Other + 1 more
Lead sponsor: Arkansas Heart Hospital; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Stimulant Abuse, Criminal Behavior
Interventions: Decision task; Other
Lead sponsor: The Mind Research Network; Other
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 334 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Same-Sex Relationships
Interventions: Better Together; Behavioral
Lead sponsor: Sharon Scales Rostosky; Other
Eligibility: 18 Years and older · Female only
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Hereditary Diseases
Interventions: Audiotaped Focus Group, Demographic Questionnaire, Audiotaped Interview, WAMMI Inventory; Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Extraintestinal Pathogenic Escherichia Coli Prevention
Interventions: ExPEC10V, ExPEC4V, Prevnar 13, Placebo; Biological
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 60 Years and older
Enrollment: 836 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 12
States / cities: Huntsville, Alabama • Melbourne, Florida • Miami, Florida + 9 more

Conditions: Cancer Pain, Opioid Use, Cognitive Behavior Therapy
Interventions: Cognitive Behavioral Therapy for pain; Behavioral
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Pulmonary Arterial Hypertension, Children
Interventions: Sildenafil citrate, Placebo; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 1 Year to 17 Years
Enrollment: 235 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 10
States / cities: Palo Alto, California • Stanford, California • Aurora, Colorado + 7 more

Conditions: Migraine Headache
Interventions: Perineural electrical dry needling, Standard Care; Procedure
Lead sponsor: Wheaton Franciscan Healthcare; Other
Eligibility: 18 Years to 100 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Pain
Interventions: Vapocoolant (Pain Ease), Nature's Tears Sterile Water; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Spinal Cord Injury, Depression - Major Depressive Disorder, Veteran
Interventions: Psilocybin (Usona Institute); Drug
Lead sponsor: James J. Peters Veterans Affairs Medical Center; Federal
Eligibility: 22 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Acne Vulgaris
Interventions: CB-03-01, Vehicle; Drug
Lead sponsor: Intrepid Therapeutics, Inc.; Industry
Eligibility: 12 Years and older
Enrollment: 363 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 13
States / cities: Los Angeles, California • San Diego, California • Sanford, Florida + 9 more

Conditions: Contingency Management, Methamphetamine Use Disorder
Interventions: Contingency management; Behavioral
Lead sponsor: Queen's Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Obesity, Obesity, Childhood, Physical Activity, Dietary Intake
Interventions: Healthy Dads Healthy Kids, Standard of care control; Behavioral · Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 5 Years to 65 Years
Enrollment: 187 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Glaucoma, Ocular Hypertension
Interventions: Latanoprost-PPDS; Drug
Lead sponsor: Mati Therapeutics Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 8
States / cities: Artesia, California • Sacramento, California • Bel Air, Maryland + 5 more

Conditions: Hypertension, Prehypertension, Overweight, Obesity, Hypertrophy, Left Ventricular
Interventions: Electronic Media Application, Standard of care education; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 13 Years to 22 Years
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Age-Related Macular Degeneration
Interventions: ASP7317, tacrolimus, trimethoprim-sulfamethoxazole, Acyclovir, Nystatin; Drug
Lead sponsor: Astellas Institute for Regenerative Medicine; Industry
Eligibility: 50 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 20
States / cities: Phoenix, Arizona • Los Angeles, California • Palo Alto, California + 16 more

Conditions: Diabetic Retinopathy
Interventions: BI 765128, Sham comparator; Drug · Other
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 11
States / cities: Bakersfield, California • Sacramento, California • Walnut Creek, California + 7 more

Conditions: Covid19
Interventions: BGB-DXP593, Placebo; Drug
Lead sponsor: BeiGene; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 181 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 11
States / cities: DeLand, Florida • Hollywood, Florida • Miami, Florida + 5 more

Conditions: Coronary Artery Disease
Interventions: Adenosine, Contrast Media, Resting conditions; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 763 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 2
States / cities: Palo Alto, California • Oklahoma City, Oklahoma

Conditions: Shigellosis
Interventions: Shigella 4V, MenACWY, Rabies, Diphtheria, Tetanus and Pertussis (DTaP), Placebo; Biological
Lead sponsor: LimmaTech Biologics AG; Industry
Eligibility: 8 Months to 50 Years
Enrollment: 597 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 0
States / cities: Not listed

Search by objective public record fields.

Assessing Repeat Fit Testing for CRC

Getting to Zero Among HHI MSM in the American South

Pounds Off Digitally (POD): The Use of Podcasting and Mobile Media to Promote Weight Loss

Dose Ranging Study of OTO-201 in AOMT

Ticagrelor and Peripheral Arterial Disease

Neurocognitive Abnormalities in Stimulant Abuse Among High-Risk Women

Better Together: A Web-based Relationship Education Tool

A Social Media Approach to Improve Genetic Risk Communication Phase I

A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health

Psychological Intervention Using Smartphone Technology to Alleviate Malignant Pain

A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension.

Peri-neural Electrical Dry Needling Migraine Treatment Study

Vapocoolant (Pain Ease) Use for Venipuncture

Psilocybin to Treat Depression in Spinal Cord Injury

A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris

Implementing a Contingency Management Program Addressing Methamphetamine Use for and With the People of Hawai'i

Efficacy Trial Healthy Dads, Healthy Kids for Hispanic Fathers and Children

Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension

EMPower: Electronic Media Powering Positive Health Changes in Youth

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTing Physiology?)

A Study to Determine If a New Shigella Vaccine is Safe, Induces Immunity and The Best Dose Among Kenyan Infants